Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rhodes

Showing results (341-350 of 353) with videos related to

Pageof 36
Sort By:
Ecology Letters|October 19, 2013
Predicting species distributions for conservation decisionsAntoine Guisan, Reid Tingley, John B Baumgartner, et al.
Cancer Discovery|April 6, 2013
Identification of targetable FGFR gene fusions in diverse cancersYi-Mi Wu, Fengyun Su, Shanker Kalyana-Sundaram, et al.
Plos Neglected Tropical Diseases|April 7, 2025
Bacillus cereus biovar anthracis causes inhalational anthrax-like disease in rabbits that is treatable with medical countermeasuresAllison M Ferris, David G Dawson, Andrea B Eyler, et al.
Nature|June 23, 2012
The mutational landscape of lethal castration-resistant prostate cancerCatherine S Grasso, Yi-Mi Wu, Dan R Robinson, et al.
Science Translational Medicine|August 5, 2011
Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSAScott A Tomlins, Sheila M J Aubin, Javed Siddiqui, et al.
The New England Journal of Medicine|July 25, 2008
Raltegravir with optimized background therapy for resistant HIV-1 infectionRoy T Steigbigel, David A Cooper, Princy N Kumar, et al.
The New England Journal of Medicine|July 25, 2008
Subgroup and resistance analyses of raltegravir for resistant HIV-1 infectionDavid A Cooper, Roy T Steigbigel, Jose M Gatell, et al.
Cancer Cell|June 10, 2008
The role of SPINK1 in ETS rearrangement-negative prostate cancersScott A Tomlins, Daniel R Rhodes, Jianjun Yu, et al.
Neoplasia (New York, N.Y.)|May 1, 2015
Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumorsDaniel H Hovelson, Andrew S McDaniel, Andi K Cani, et al.
Cancer Research Communications|July 27, 2023
Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 BenefitBenjamin J Bulen, Nickolay A Khazanov, Daniel H Hovelson, et al.
Pageof 36

Showing results (341-350 of 353) with videos related to

Sort By:
Pageof 36
Ecology Letters|October 19, 2013
Predicting species distributions for conservation decisionsAntoine Guisan, Reid Tingley, John B Baumgartner, et al.
Cancer Discovery|April 6, 2013
Identification of targetable FGFR gene fusions in diverse cancersYi-Mi Wu, Fengyun Su, Shanker Kalyana-Sundaram, et al.
Plos Neglected Tropical Diseases|April 7, 2025
Bacillus cereus biovar anthracis causes inhalational anthrax-like disease in rabbits that is treatable with medical countermeasuresAllison M Ferris, David G Dawson, Andrea B Eyler, et al.
Nature|June 23, 2012
The mutational landscape of lethal castration-resistant prostate cancerCatherine S Grasso, Yi-Mi Wu, Dan R Robinson, et al.
Science Translational Medicine|August 5, 2011
Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSAScott A Tomlins, Sheila M J Aubin, Javed Siddiqui, et al.
The New England Journal of Medicine|July 25, 2008
Raltegravir with optimized background therapy for resistant HIV-1 infectionRoy T Steigbigel, David A Cooper, Princy N Kumar, et al.
The New England Journal of Medicine|July 25, 2008
Subgroup and resistance analyses of raltegravir for resistant HIV-1 infectionDavid A Cooper, Roy T Steigbigel, Jose M Gatell, et al.
Cancer Cell|June 10, 2008
The role of SPINK1 in ETS rearrangement-negative prostate cancersScott A Tomlins, Daniel R Rhodes, Jianjun Yu, et al.
Neoplasia (New York, N.Y.)|May 1, 2015
Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumorsDaniel H Hovelson, Andrew S McDaniel, Andi K Cani, et al.
Cancer Research Communications|July 27, 2023
Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 BenefitBenjamin J Bulen, Nickolay A Khazanov, Daniel H Hovelson, et al.
Pageof 36